The National Institute for Health and Care Excellence (NICE) has recommended FILSPARI (sparsentan) for use in the NHS in ...

With over 55 million people worldwide living with dementia, Oxford Brain Diagnostics (OBD) is set to revolutionise early diagnosis with its patented Cortical Disarray Measurement (CDM®) technology.

The study met its primary endpoint, with a statistically significant placebo-adjusted 61% and 58% reduction in triglyceride ...

The Board of the Medicines and Healthcare products Regulatory Agency (MHRA) has met in Scotland for the first time, marking a ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved guselkumab (Tremfya) for the treatment of Crohn’s ...

Co-founded by Landmark BioVentures and researchers from Aix-Marseille University, Massalia Therapeutics builds on 20 years of ...

The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals’ Brekiya (dihydroergotamine mesylate) injection ...

Sonrai Analytics and AOA Dx have announced a partnership to accelerate the development of AOA’s multi-omic liquid biopsy test ...

Kaerus Bioscience has received orphan drug and rare paediatric drug designations from the FDA for KER-0193, its lead ...

Kelso Pharma has announced the appointment of Bee Koen Low as its first Chief Operating Officer. Low brings more than 20 ...

Apiary Capital has completed its investment in performance-io (PIO), a leading life sciences performance marketing and search engine optimization agency, supporting its international expansion and ...

Herantis Pharma has dosed the first patients in the final cohort of its phase 1b clinical trial assessing HER-096, a disease-modifying treatment for Parkinson’s disease. The study aims to evaluate the ...